Defence Therapeutics Announces Securities for Debenture Financing
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Vaccine
Health and Wellness Market to Grow by USD 1.93 Trillion (2024-2028), Driven by Rising Focus on Health Programs, AI-Powered Report Highlights Market Evolution – Technavio
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global health and...
Defence Announces Radiopharmaceutical Expert Svetlana Selivanova Joins Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - November 13, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...
Healthcare BPO Market to Grow by USD 17.30 Billion (2024-2028), Driven by Focus on Reducing Operational Costs, AI-Powered Report Highlights Market Transformation – Technavio
NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global healthcare business...
SmoothSkin Introduces Groundbreaking DuoLux Innovations in LED Red Light Therapy
Revolutionizing skincare with cutting-edge LED technology to rejuvenate and enhance skin health. NEW YORK, Nov. 12, 2024 /PRNewswire/ -- SmoothSkin, a...
Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development
PARIS and NEW YORK and SAN FRANCISCO, Nov. 12, 2024 /PRNewswire/ -- Today, Formation Bio, together with OpenAI and Sanofi, introduced...
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to MedRxiv and BioRxiv, Respectively
CANOPY manuscript preprint includes six-month off-drug follow-up period that highlighted strong protection by pemivibart versus placebo in the immunocompetent Cohort...
The Arthritis Foundation Welcomes Zoetis as Two-Year National Presenting Sponsor of Jingle Bell Run and Walk to Cure Arthritis
The partnership joins forces to support arthritis patients and their beloved pets ATLANTA, GA / ACCESSWIRE / November 12, 2024...
Moderna Tops BioSpace’s Best Places to Work Ranking for Fourth Consecutive Year
CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one...
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2024 and Provides Business Update
Strengthened Cash, Strategic Refocus and Pipeline Progress Define Transformative Quarter€400 million upfront payment from restructured GSK collaboration reflected in financials,...
Maravai LifeSciences Announces November 2024 Investor Conference Schedule
SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents...
Evaxion announces positive preclinical data for cytomegalovirus (CMV) vaccine program EVX-V1
New preclinical data demonstrates that CMV antigens identified with Evaxion’s AI-Immunology™ platform trigger targeted immune responses Results also showcase the...
The Galien Foundation Honors 2024 Prix Galien Award Recipients
Winners received prestigious award in recognition of latest innovations in advancement in life sciences NEW YORK, Nov. 8, 2024 /PRNewswire/...
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
mRESVIA is Moderna's second approved product in Canada, the first mRNA vaccine against RSV, and the only one in single-dose...
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences...
New England Biolabs® Expands Lyophilization Capabilities with Opening of Manufacturing Facility in the UK
New England Biolabs Lyophilization Sciences® further strengthens its ability to deliver a best-in-class solution for customers in need of lyophilized...
Thompson Street Capital Partners Portfolio Company Savillex Acquires Optimum Processing, Inc.
ST. LOUIS, Nov. 7, 2024 /PRNewswire/ -- Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis,...
CureVac to Report Third Quarter and First Nine Months 2024 Financial Results and Business Update on November 12, 2024
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 7, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03Achieves year-to-date product...
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
Partnerships will employ Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discoveryROCHESTER, N.Y., Nov. 07, 2024...